IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
IMMUNOPHARM IMMUNOT
ISSN / eISSN
0892-3973 / 1532-2513
Aims and Scope
The journal Immunopharmacology and Immunotoxicology is devoted to pre-clinical and clinical drug discovery and development targeting the immune system. Research related to the immunoregulatory effects of various compounds, including small-molecule drugs and biologics, on immunocompetent cells and immune responses, as well as the immunotoxicity exerted by xenobiotics and drugs. Only research that describe the mechanisms of specific compounds (not extracts) is of interest to the journal.
The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome.
With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more.
Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).
The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome.
With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more.
Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).
Subject Area
TOXICOLOGY
IMMUNOLOGY
PHARMACOLOGY & PHARMACY
CiteScore
4.60
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - Pharmacology | Q2 | #147/301 |
| Pharmacology, Toxicology and Pharmaceutics - Toxicology | Q3 | #64/124 |
| Pharmacology, Toxicology and Pharmaceutics - Immunology and Allergy | Q3 | #122/211 |
| Pharmacology, Toxicology and Pharmaceutics - Immunology | Q3 | #143/217 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| IMMUNOLOGY - SCIE | Q3 |
| PHARMACOLOGY & PHARMACY - SCIE | Q3 |
| TOXICOLOGY - SCIE | Q2 |
H-index
42
Country/Area of Publication
UNITED STATES
Publisher
Informa Healthcare
Publication Frequency
Quarterly
Annual Article Volume
133
Open Access
NO
Contact
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106
Verified Reviews
In mid-2018, I passed one paper, and now I am sharing the timeline for reference.
2018-8-30: Submitted
2018-9-30: Minor revision
2018-11-10: Re-submitted
2018-12-3: Accepted
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search